Allergic Rhinitis Due to Olea Europaea Pollen Clinical Trial
Official title:
An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy
This trial is an open, national, multi-centre trial. The trial will be initiated after olive
pollen season 2012 and subjects will receive treatment for 6 weeks.
The aim of study is to assess the tolerability of the up-dosing phase of AVANZ Olive. The
frequency of patients with adverse reactions will be the primary endpoint.
Frequency of patients with systemic reactions according to EAACI classification, increase in
IgG4 and in IgE and reduction in immediate skin reactivity.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment